Tirzepatide emerges a groundbreaking therapeutic agent for individuals struggling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://henrieaiy892951.bloggip.com/40918567/tirzepatide-a-new-frontier-in-diabetes-treatment